Syngenta Crop Protection, a leader in agricultural innovation, and Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, today announced a new cooperation to accelerate the launch of a new biological solution. The two companies have previously collaborated on next-generation seed technology.

Through this new collaboration, Ginkgo plans to develop and optimise a microbial strain to meet the productivity targets of a secondary metabolite from the Syngenta Biologicals pipeline. Syngenta has earmarked this molecule as a pioneering biological solution. Successful, cost-effective, and large-scale production of this targeted metabolite would significantly expedite Syngenta’s go-to-market timeline for its latest biological solution.

To achieve this, Ginkgo will use its Ag Biologicals capabilities to calculate theoretical performance and guide rational strain engineering strategies to develop the microbial strain that is robust enough to meet Syngenta’s goals. Ginkgo will leverage its biological knowledge and machine learning approaches to create insights from multiple complex data sources and apply this toward diagnosing strain performance limitations and biological feature discovery.

Read The Full Article Here – Syngenta and ginkgo bioworks